دورية أكاديمية
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia.
| العنوان: | Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia. |
|---|---|
| المؤلفون: | de Oliveira Costa, Juliana, Lin, Jialing, Milder, Tamara Y, Greenfield, Jerry R, Day, Richard O, Stocker, Sophie L, Neuen, Brendon L, Havard, Alys, Pearson, Sallie-Anne, Falster, Michael O |
| المصدر: | Diabetes Obes Metab ; ISSN:1463-1326 ; Volume:26 ; Issue:7 |
| بيانات النشر: | Wiley |
| سنة النشر: | 2024 |
| المجموعة: | PubMed Central (PMC) |
| مصطلحات موضوعية: | geographic variation, glucagon‐like peptide‐1 receptor agonists, pharmacoepidemiology, sodium‐glucose cotransporter 2 inhibitor, type 2 diabetes |
| الوصف: | Sodium-glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) improve glycaemic control and cardio-renal outcomes for people with type 2 diabetes (T2D). However, geographic and socio-economic variation in use is not well understood. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.1111/dom.15597Test; https://pubmed.ncbi.nlm.nih.gov/38618983Test |
| DOI: | 10.1111/dom.15597 |
| الإتاحة: | https://doi.org/10.1111/dom.15597Test https://pubmed.ncbi.nlm.nih.gov/38618983Test |
| حقوق: | © 2024 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. |
| رقم الانضمام: | edsbas.8CFD26FF |
| قاعدة البيانات: | BASE |
| DOI: | 10.1111/dom.15597 |
|---|